Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 18Neoplasms 6Rectal Neoplasms 4Colonic Neoplasms 4Neoplasm Metastasis 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Tongue Neoplasms 1Pancreatic Neoplasms 1Oesophago-gastric Cancer 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1

Interventions

Radiotherapy, Intensity-Modulated 2Fluorouracil 2Cisplatin 2Chemotherapy, Adjuvant 2sargramostim 1dehydroftorafur 1aldesleukin 1Salts 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Panitumumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Doxepin 1Docetaxel 1Disulfides 1Cetuximab 1Carboplatin 1Bevacizumab 1Allovectin-7 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Tongue Neoplasms × Panitumumab × Clear all
NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡